Home » Xeomin Approved for New Indication in EU
Xeomin Approved for New Indication in EU
Merz Pharmaceuticals announced that European health authorities have reached an agreement on
a new indication of Xeomin for the symptomatic treatment of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in
adults.
CNW Group
CNW Group
Upcoming Events
-
07May
-
14May
-
30May